XML 29 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Class A Warrants
Class B Warrants
Class C Warrants
Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Class A Warrants
Additional Paid-in Capital
Class B Warrants
Additional Paid-in Capital
Class C Warrants
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2020         5,563,358              
Beginning balance (in shares) at Dec. 31, 2020           9,780,547            
Beginning balance at Dec. 31, 2020 $ (5,341)       $ 1,631 $ 0 $ 16,937       $ (23,954) $ 45
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation (in shares)           67            
Share-based compensation 3           3          
Hedging activity 3 [1]                     3
Net income 5,383                   5,383  
Cancellation of Predecessor Equity (in shares)         (5,563,358) (9,780,614)            
Cancellation of Predecessor equity (48)       $ (1,631)   (16,940)       18,571 (48)
Issuance of Successor common stock (in shares)           97,907,081            
Issuance of Successor common stock 3,331         $ 1 3,330          
Issuance of warrants   $ 93 $ 94 $ 68       $ 93 $ 94 $ 68    
Preferred stock, shares outstanding, end of period (in shares) at Feb. 09, 2021         0              
Ending balance (in shares) at Feb. 09, 2021           97,907,081            
Ending balance at Feb. 09, 2021 3,586       $ 0 $ 1 3,585       0 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation (in shares)           248,487            
Share-based compensation 21           21          
Issuance of common stock for Acquisition (in shares)           18,709,399            
Issuance of common stock for Acquisition 1,237           1,237          
Issuance of common stock for warrant exercise (in shares)           188,292            
Issuance of common stock for warrant exercise 2           2          
Issuance of reserved common stock and warrants (in shares)           864,090            
Hedging activity [1] 0                      
Net income 945                   945  
Dividends on common stock (120)                   (120)  
Preferred stock, shares outstanding, end of period (in shares) at Dec. 31, 2021         0              
Ending balance (in shares) at Dec. 31, 2021           117,917,349            
Ending balance at Dec. 31, 2021 5,671       $ 0 $ 1 4,845       825 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation (in shares)           174,740            
Share-based compensation 21           21          
Issuance of common stock for Acquisition (in shares)           9,442,185            
Issuance of common stock for Acquisition 764           764          
Issuance of common stock for warrant exercise (in shares)           2,102,244            
Issuance of common stock for warrant exercise 27           27          
Repurchase and retirement of common stock (in shares)           (11,666,778)            
Repurchase and retirement of common stock (1,073)                   (1,073)  
Issuance of common stock for warrant exchange offer (in shares)           16,305,984            
Issuance of common stock for warrant exchange offer 67           67          
Issuance of reserved common stock and warrants (in shares)           439,370            
Hedging activity [1] 0                      
Net income 4,936                   4,936  
Dividends on common stock (1,222)                   (1,222)  
Deemed dividend on warrants (67)                      
Preferred stock, shares outstanding, end of period (in shares) at Dec. 31, 2022         0              
Ending balance (in shares) at Dec. 31, 2022           134,715,094            
Ending balance at Dec. 31, 2022 9,124       $ 0 $ 1 5,724       3,399 0
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2021         0              
Beginning balance (in shares) at Dec. 31, 2021           117,917,349            
Beginning balance at Dec. 31, 2021 $ 5,671       $ 0 $ 1 4,845       825 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Repurchase and retirement of common stock (in shares) (16,040,000)                      
Repurchase and retirement of common stock $ (1,430)                      
Preferred stock, shares outstanding, end of period (in shares) at Dec. 31, 2023         0              
Ending balance (in shares) at Dec. 31, 2023           130,789,936            
Ending balance at Dec. 31, 2023 10,729       $ 0 $ 1 5,754       4,974 0
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2022         0              
Beginning balance (in shares) at Dec. 31, 2022           134,715,094            
Beginning balance at Dec. 31, 2022 9,124       $ 0 $ 1 5,724       3,399 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation (in shares)           214,684            
Share-based compensation 31           31          
Issuance of common stock for warrant exercise (in shares)           221,952            
Repurchase and retirement of common stock (in shares)           (4,373,883)            
Repurchase and retirement of common stock (358)           (1)       (357)  
Issuance of reserved common stock and warrants (in shares)           12,089            
Hedging activity [1] 0                      
Net income 2,419                   2,419  
Dividends on common stock (487)                   (487)  
Preferred stock, shares outstanding, end of period (in shares) at Dec. 31, 2023         0              
Ending balance (in shares) at Dec. 31, 2023           130,789,936            
Ending balance at Dec. 31, 2023 $ 10,729       $ 0 $ 1 $ 5,754       $ 4,974 $ 0
[1] Deferred tax activity incurred in other comprehensive income was offset by a valuation allowance.